Mutual of America Capital Management LLC Increases Stock Holdings in Humana Inc. (NYSE:HUM)

Mutual of America Capital Management LLC increased its holdings in shares of Humana Inc. (NYSE:HUM) by 12.4% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 21,717 shares of the insurance provider’s stock after buying an additional 2,395 shares during the quarter. Mutual of America Capital Management LLC’s holdings in Humana were worth $6,879,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also recently added to or reduced their stakes in HUM. Creative Financial Designs Inc. ADV lifted its holdings in shares of Humana by 244.0% during the 3rd quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider’s stock worth $27,000 after acquiring an additional 61 shares during the period. CarsonAllaria Wealth Management Ltd. raised its stake in Humana by 111.4% during the second quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider’s stock worth $28,000 after purchasing an additional 39 shares during the period. Atwood & Palmer Inc. acquired a new position in shares of Humana in the 3rd quarter valued at $29,000. Ashton Thomas Securities LLC purchased a new stake in shares of Humana during the 3rd quarter valued at $31,000. Finally, Your Advocates Ltd. LLP increased its holdings in shares of Humana by 81.8% during the 3rd quarter. Your Advocates Ltd. LLP now owns 100 shares of the insurance provider’s stock worth $32,000 after buying an additional 45 shares during the last quarter. 92.38% of the stock is owned by institutional investors and hedge funds.

Humana Trading Down 1.6 %

NYSE HUM opened at $271.35 on Tuesday. The company has a market capitalization of $32.67 billion, a price-to-earnings ratio of 24.03, a price-to-earnings-growth ratio of 2.17 and a beta of 0.52. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.76 and a quick ratio of 1.76. Humana Inc. has a 12 month low of $213.31 and a 12 month high of $527.18. The company’s fifty day moving average price is $279.91 and its two-hundred day moving average price is $331.59.

Humana (NYSE:HUM) last issued its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $4.16 EPS for the quarter, topping the consensus estimate of $3.48 by $0.68. The business had revenue of $29.30 billion for the quarter, compared to analysts’ expectations of $28.66 billion. Humana had a net margin of 1.18% and a return on equity of 13.20%. As a group, research analysts predict that Humana Inc. will post 15.86 earnings per share for the current fiscal year.

Humana Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Tuesday, December 31st will be given a $0.885 dividend. The ex-dividend date is Tuesday, December 31st. This represents a $3.54 annualized dividend and a dividend yield of 1.30%. Humana’s payout ratio is 31.36%.

Analyst Upgrades and Downgrades

HUM has been the topic of a number of research analyst reports. Cantor Fitzgerald reiterated a “neutral” rating and issued a $395.00 target price on shares of Humana in a report on Tuesday, October 1st. Stephens reissued an “equal weight” rating and set a $250.00 target price on shares of Humana in a research report on Wednesday, October 9th. Wells Fargo & Company reduced their price target on shares of Humana from $387.00 to $290.00 and set an “overweight” rating on the stock in a research report on Monday, November 4th. Oppenheimer dropped their price objective on shares of Humana from $400.00 to $280.00 and set an “outperform” rating for the company in a research report on Thursday, October 3rd. Finally, Jefferies Financial Group lowered shares of Humana from a “buy” rating to a “hold” rating and reduced their target price for the company from $519.00 to $253.00 in a report on Monday, October 7th. Twenty equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $315.86.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.